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Abstract
Background: A linguistic validation of the Self-Assessment Goal Achievement (SAGA) questionnaire was conducted
for 12 European languages, documenting that each translation adequately captures the concepts of the original
English-language version of the questionnaire and is readily understood by subjects in the target population.
Methods: Native-speaking residents of the target countries who reported urinary problems/lower urinary tract
problems were asked to review a translation of the SAGA questionnaire, which was harmonized among 12
languages: Danish, Dutch, English (UK), Finnish, French, German, Greek, Icelandic, Italian, Norwegian, Spanish, and
Swedish. During a cognitive debriefing interview, participants were asked to identify any words that were difficult
to understand and explain in their own words the meaning of each sentence in the questionnaire. The qualitative
analysis was conducted by local linguistic validation teams (original translators, back translator, project manager,
interviewer, and survey research expert).
Results: Translations of the SAGA questionnaire from English to 12 European languages were well understood by
the participants with an overall comprehension rate across language of 98.9%. In addition, the translations retained
the original meaning of the SAGA items and instructions. Comprehension difficulties were identified, and after
review by the translation team, minor changes were made to 7 of the 12 translations to improve clarity and
comprehension.
Conclusions: Conceptual, semantic, and cultural equivalence of each translation of the SAGA questionnaire was
achieved thus confirming linguistic validation.
Keywords: SAGA, Validation, Lower urinary tract symptoms, Overactive bladder, Goal achievement, Patient-reported
questionnaire
Background
Overactive bladder (OAB) is a chronic condition with a
prevalence of approximately 11% in men and 13% in
women in Europe [1]. Despite a significant armamentar-
ium of effective agents available for the treatment of
overactive bladder, many patients with OAB symptoms
do not discuss their symptoms with their healthcare
provider and remain untreated. In addition, once symp-
toms are identified and patients are treated, they often
discontinue treatment when their expectations are not
achieved [2]. Successful management of OAB and lower
urinary tract symptoms (LUTS) may be contingent on
patients having realistic treatment goals and on clini-
cians understanding which treatment goals are most
important, for example, those symptoms that have the
greatest severity or debilitating impact on patients’ lives.
The Self-Assessment Goal Achievement (SAGA) ques-
tionnaire is a communication tool designed to help
patients with LUTS and their healthcare providers adopt
reasonable treatment expectations and assess goal
achievement [3-5]. Developing realistic treatment expec-
tations and attaining those goals may lead to improved
treatment outcomes, a concept observed in other
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any medium, provided the original work is properly cited.therapeutic areas [6,7]. Briefly, the baseline SAGA mod-
ule asks patients to rate the importance of 9 prespecified
(fixed) treatment goals that describe reducing the fol-
lowing LUTS: frequency (daytime and nighttime); sensa-
tion of pressure; primary sensation to use the bathroom;
bladder voiding; starting or maintaining a urine stream;
urine loss when coughing, laughing, exercising, or sneez-
ing; urine leakage; and urgency. In addition to the 9
fixed goals, patients can list up to 5 additional (open)
treatment goals. Patients rate the importance of each
goal using a 5-point scale ranging from “not very impor-
tant goal” to “very important goal.” In the SAGA follow-
up module, patients rate their achievement of each indi-
vidualized goal and overall goal achievement with a 5-
point scale ranging from “did not achieve goal” to
“greatly exceeded goal.” SAGA is the first questionnaire
to capture individualized treatment expectations and
goals regarding LUTS [8,9].
European regulatory bodies have raised concerns over
the validity of measures developed in one language and
then used in other languages [10]. The European Regula-
tory Issues and Quality of Life Assessment (ERIQA)
Group recommends that a rigorous approach is taken in
the translation of patient-reported outcome (PRO) mea-
sures for use in international settings to achieve concep-
tual and semantic equivalence across languages [11].
Guidance for gaining this evidence is provided in a publi-
cation generated by the International Society for Pharma-
coeconomics and Outcomes Research (ISPOR), entitled
Multinational Trials - Recommendations on the Transla-
tions Required, Approaches to Using the Same Language
in Different Countries, and the Approaches to Support
Pooling the Data: The ISPOR Patient-Reported Outcomes
Translation and Linguistic Validation Good Research
Practices Task Force Report,[12] which was developed to
expand on a previous publication (2005) that provided
guidance for the translation of PRO measures [13].
Because there exists an increased need to translate and
culturally adapt PRO measures, the document details
areas designed to maintain content integrity during
translation. Similarly, the US Food and Drug Administra-
tion recommends that language translations of PRO
instruments being used in countries where the language
is not the same as the country in which the instrument
was developed show evidence that the content validity
and other measurement properties of the instrument
remain equivalent to those of the original version [14].
A harmonized translation of the SAGA questionnaire
was created in 12 languages: Danish, Dutch, English
(UK), Finnish, French, German, Greek, Icelandic, Italian,
Norwegian, Spanish, and Swedish. The objective of the
present study was to conduct a linguistic validation of
t h eS A G Aq u e s t i o n n a i r ef o rt h o s e1 2E u r o p e a nl a n -
guages to document that each translation adequately
captures the concepts of the original English-language
version of the questionnaire and is readily understood
by subjects in the target population.
Methods
Participants
Participants were recruited by clinical investigators
through referrals. Participants had to be native-speaking
residents of the target countries who reported urinary
problems/lower urinary tract problems. Subject selection
criteria for each language, assuming a sample of 8 parti-
cipants per language, were patients with self-reported
urinary problems/lower urinary tract problems, equal
representation of gender, and (when possible) ≥ 2 parti-
cipants with fewer than 12 years of education, ≤ 2 parti-
cipants per 10-year age range and a minimum range of
30 years between the youngest and oldest subject, and ≥
3 geographical areas in the target country.
Linguistic validation
A schematic overview of a typical linguistic validation
process is illustrated in Figure 1. The methodology to
conduct the linguistic validation of SAGA was based on
linguistic adaptation principles detailed by the European
Regulatory Issues and Quality of Life Assessment
(ERIQA) Group [11] and the International Society for
Pharmacoeconomics and Outcomes Research (ISPOR)
[12,13] and recommended by the US Food and Drug
Administration [14].
Translations were created by linguists meeting the cul-
tural, technical, and linguistic standards of competence
through a process of forward and back translations and
review by an expert in survey research and a local user,
in accordance with industry standards outlined in
Appendix A. A harmonized translation of the SAGA
questionnaire was created in 12 languages: Danish,
Dutch, English (UK), Finnish, French, German, Greek,
Icelandic, Italian, Norwegian, Spanish, and Swedish. The
translations were then tested via cognitive debriefing
interviews of patients with OAB residing in the target
countries. Cognitive debriefing is a standardized inter-
view conducted by a trained interviewer following a sub-
ject’s review and completion of a PRO instrument. All
interactions with participants were conducted in the tar-
get language only. The source language was never used
in discussing the document with the subject. Bilingual
interviewers (English and target language) were trained
to conduct one-on-one cognitive debriefing interviews
as previously described [15].
Study procedures
Participants were asked to review the SAGA question-
naire during a baseline interview and in the follow-up
module, to return the questionnaire with any words,
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stand. During a subsequent debriefing telephone inter-
view, participants were asked to paraphrase each
sentence in the questionnaire and explain why any
circled words were difficult to understand. Comprehen-
sion rates (defined as total percentage of subjects who
were able to successfully paraphrase the items within this
instrument) were captured during debriefing interviews.
Interviewing was conducted using a script that was read
to the participants: “As you know, we are testing a ques-
tionnaire for use in clinical studies and want to know if
t h e yc a nb ee a s i l yu n d e r s t o o d .D i dy o uh a v eac h a n c et o
review the document and circle any words that you
found difficult to understand or any questions that were
difficult to answer?” The interviewer judged whether
items were correctly paraphrased and recorded any com-
prehension problems or proposed changes to the word-
ing. In keeping with regulatory guidelines and good
clinical practice, cognitive debriefing information was
captured on a data collection form (Appendix B).
In the subsequent qualitative analysis, linguistic valida-
tion teams, consisting of the original translators, back
translator, project manager, interviewer, and survey
research expert, evaluated the debriefing results. The
teams categorized problems that emerged during the
debriefing as: Conceptual - a function of the original
English; Linguistic - a function of the words used to
translate the English concept; or Stylistic - a function of
the subject’s preference for a different wording. When
warranted, the original translators of the questionnaire
created a new harmonized translation of problem words
or sentences and the back translator created a new back
translation for review by a survey research expert. Once
all issues were resolved, final forward and back transla-
tions were created.
Results
Participants
After creating comprehensive translations, which were
approved by the translators, project manager, and survey
Figure 1 Overview of a typical linguistic evaluation process.
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interviews were conducted with 144 participants with
urinary/lower urinary tract problems from 16 countries:
Denmark, The Netherlands, Finland, United Kingdom,
Ireland, Greece, Norway, Iceland, Spain, Sweden, France,
Belgium, Luxembourg, Switzerland, Italy, Germany. The
participants ranged in age from 18 to 87 years and had
4 to 24 years of education (Table 1). An equal number
of men and women participants in each language sam-
ple were included. The age range in the Danish popula-
tion was < 30 years (60-79 y).
Cognitive debriefing
A breakdown of item comprehension by language is
summarized in Table 2. The average item comprehen-
sion rate for each item in the SAGA questionnaire,
across languages, was 98.9%. A summary of the compre-
hension difficulties for each SAGA item is listed in
Table 3. For most difficulties, the terms were judged by
the translation team to not require changes because the
overall comprehension levels were relatively high and
the translated terms were accurately rendered in the tar-
get languages. The various types of changes that were
required are summarized in Table 4 with the majority of
changes made to the questionnaire instructions. No
changes were made for the Danish, Spanish, and Swed-
ish translated versions. For the Greek, Italian, Norwe-
gian, German, and English (Irish and UK) versions,
comprehension difficulties that required changes
occurred only in the instructions for the questionnaire.
For example, “Finally, circle the three most important
goals in the combined symptom and other personal
goals sections, as shown below” was the most common
statement that was incorrectly paraphrased, with an
88.1% comprehension rate. Therefore, this instruction
was changed for greater conceptual clarity. Examples of
other changes include: for the Dutch translation, all
changes were made to the instructions, including a
comma inserted after “treatment goals” for greater con-
ceptual clarity: “Each patient is unique and has different
treatment goals, depending on the symptoms experi-
enced, lifestyle, and any other health concerns” and
“Use the scale below...” w a sr e p l a c e db ym o r ec o m m o n
terms for the target countries. This revision was made
throughout the questionnaire. In the French version,
examples of changes made were: in the instructions,
“Circle the 3 goals from the combined sections below
(Symptom and Other personal goals) which are the
most important for you” was revised for greater concep-
tual clarity; and in the item “To reach my goals I will:”
the phrase “Keep record of my progress” was revised as
“Keep track of my progress” for both greater conceptual
Table 1 Demographic characteristics of the participants by target language*
Language Residence (number of towns/cities) Age
(years)
Gender
(males/females)
Education (years)
Danish Denmark (8) 60 - 79 4:4 7 - 15
Dutch Belgium, Netherlands (16) 31 - 85 8:8 6 - 16
English Ireland, United Kingdom (10) 29 - 71 8:8 11 - 18
Finnish Finland (4) 21 - 77 4:4 13 - 24
French Belgium, France, Luxembourg, Switzerland (24) 25 - 86 16:16 5 - 19
German Germany, Switzerland (15) 27 - 78 8:8 9 - 18
Greek Greece (3) 32 - 87 4:4 4 - 16
Icelandic Iceland (6) 23 - 70 4:4 14 - 18
Italian Italy (5) 40 - 74 4:4 5 - 17
Norwegian Norway (6) 20 - 76 4:4 7 - 16
Spanish Spain (6) 18 - 55 4:4 9 - 18
Swedish Sweden (7) 27 - 73 4:4 10 - 16
* n = 8 for each country
Table 2 Item Comprehension Rate by Language
Language n Comprehension Rate, %
Danish 8 100
Dutch 16 97.8
English 16 100
Finnish 8 99.9
French 32 98.8
German 16 99.8
Greek 8 99.7
Icelandic 8 99.3
Italian 8 94.1
Norwegian 8 96.8
Spanish 8 100
Swedish 8 100
Overall 144 98.9
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Item Category Incorrectly
Paraphrased
ItCR
INITIAL ASSESSMENT Title 3 97.9%
Each patient is unique and has different treatment goals depending on the symptoms experienced,
lifestyle, and any other health concerns.
Instructions 3 97.9%
A goal is something that you would like to improve by treatment. Instructions 1 99.3%
It may be a symptom that you would like to improve, or an activity that you cannot do because of your
urinary symptoms.
Instructions 1 99.3%
This questionnaire, the Self-Assessment Goal Achievement Questionnaire, is designed to record your
goals for the treatment of your urinary problems.
Instructions 10 93.0%
There are two sections to complete. Instructions 3 97.9%
The first, symptom goals, relates to the typical urinary symptoms of patients like you; you may have all or
some of these symptoms.
Instructions 2 98.6%
The second section, other personal goals, relates to the specific impact on your life from your urinary
symptoms.
Instructions 2 98.6%
Examples of other personal goals include being able to visit family and friends for a longer period of
time before having to find a restroom, or to reduce the number of times it is necessary to change
clothes due to urine loss.
Instructions 1 99.3%
Please use the questionnaire to indicate which goals are important to you and how important each goal
is by marking the appropriate box beside each goal.
Instructions 3 97.9%
Finally, circle the three most important goals in the combined symptom and other personal goals
sections, as shown below.
Instructions 17 88.1%
Take the completed form with you when you see your healthcare provider so that together you can
discuss your urinary problems, your treatment goals, review your treatment options, and develop and
commit to your treatment plan.
Instructions 1 99.3%
Your treatment goals - First Visit Title 1 99.3%
Use the scale below which ranges from 1 (not important goal) to 5 (very important goal). Instructions 1 99.3%
Circle the three goals from the combined sections below (Symptom and Other personal goals) which are
the most important for you.
Question 17 88.1%
Reduce my urine loss when I have a sudden need to rush to the bathroom Response
Option
1 99.3%
Other personal goals Response
Option
1 99.3%
(not included above and important to me) Response
Option
3 97.9%
Once you and your healthcare provider have discussed your goal(s) and developed a plan of action,
mark the actions below which will apply to you.
Question 7 95.1%
Sign your name to confirm your commitment to working towards your own better health. Instructions 1 99.3%
Read health tips about my condition Response
Option
2 98.6%
Keep record of my progress Response
Option
5 96.5%
FOLLOW-UP ASSESSMENT Title 11 92.3%
The initial assessment provided you with an opportunity to discuss your treatment goals related to your
urinary problems with your healthcare provider.
Instructions 1 99.3%
Since that discussion, have you reached your goals? Question 1 99.3%
First, look over the treatment goals you and your healthcare provider discussed during your last visit. Instructions 1 99.3%
Much worse than expected Response
Option
2 98.6%
As expected Response
Option
2 98.6%
Much better than expected Response
Option
2 98.6%
After you have completed the questionnaire, take it with you when you see your healthcare provider so
that together you can discuss your treatment goal achievement and further management of your urinary
symptoms.
Instructions 2 98.6%
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sion had 2 changes to improve grammatical accuracy: in
the item “Reduce the difficulty starting or maintaining a
urinary stream” ap r e p o s i t i o nw a sa d d e d ,a n di nt h e
item “Sign your name to confirm your commitment to
working towards your own better health” noun case was
changed.
Discussion
The primary validation study of the SAGA questionnaire
has recently demonstrated that the instrument helped
patients adopt reasonable treatment expectations and
assess goal achievement [16]. Telephone interviews,
which were used as a means of obtaining information in
this study, have been shown to be acceptable means of
capturing accurate information in other medical disci-
plines [17,18]. Multiple language iterations of the SAGA
questionnaire should facilitate wide-spread utilization of
this PRO instrument in subjects with LUTS. The results
of the cognitive debriefing interviews indicated that the
translations of the SAGA questionnaire into 12 Eur-
opean languages adequately captured the concepts of
the original English-language version of the question-
naire and were readily understood by participants with
urinary/lower urinary tract problems.
Recently, various PRO measures for assessing OAB
were translated and assessed for linguistic validity by
McKown et al.,[19] including the Nocturia Quality of
Life (N-QOL) questionnaire, Overactive Bladder Ques-
tionnaire (OAB-q) family, Patient Perception of Blad-
der Condition (PPBC) questionnaire, Overactive
Bladder Satisfaction Questionnaire (OAB-S) and
International Consultation on Incontinence Question-
naire (ICIQ) Male Sexual Matters associated with
Lower Urinary Tract Symptoms Questionnaire (ICIQ-
MLUTSsex). Like the findings reported here for the
SAGA questionnaire, McKown et al. found that the
translations were well-understood by in-country,
native-speaking subjects [19]. Also consistent with our
findings for the SAGA questionnaire, a number of
minor changes were made to the N-QOL, OAB-q,
OAB-S, and ICIQ-MLUTSsex translations to improve
clarity and cultural appropriateness.
The SAGA questionnaire was developed based on goal
attainment scaling methods to facilitate the patient-pro-
vider interaction and the tailoring of a treatment plan
based on individual patients’ goals, with the aim of
increasing patient satisfaction and improving therapeutic
outcomes [20]. The SAGA questionnaire provides a
patient perspective on treatment goals and expectations
that is not attained with other instruments assessing
LUTS. The concepts of “treatment goals and expecta-
tions” are novel for PRO measures, and different cul-
tures use varying terms to capture this information.
Both the identification and prioritization of treatment
goals and the translation and understanding of the lan-
guage nuances are critical for successful gathering of
this information. For example, while the term “goal” is
used in the United States, the term “objective” is used in
Europe, so the latter term is used, where appropriate, in
the translated questionnaires for cultural appropriate-
ness and greater conceptual clarity. In the instructions
for the questionnaires, various language iterations had
the word “goals” replaced.
Table 4 Types of Changes Required To Resolve Comprehension Difficulties
Language Spelling/Grammar Comprehension Conceptual Instructions Cultural Appropriateness
Dutch X X X X
English X X X
Finnish X
French X X X
German X X X
Greek X X
Icelandic X
Italian X X
Norwegian X X X X
Table 3 Comprehension Difficulties by SAGA Item (Continued)
Your treatment goal achievement - Follow-up Visit Title 1 98.6%
CUT OUT THE GRAY SQUARE to see your other personal goals Administrative 12 99.3%
When answering the following question, please think about all of your goals. Question 1 97.6%
Overall, to what extent have you achieved your goals? Question 1 99.3%
ItCR = item comprehension rate.Note: No changes were made for Spanish, Danish, and Swedish languages.
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Subject 1 2 3 4 5
Age (years)
Gender
Academic Education (years)
City and country of residence
Elapsed time for interview
Item
1
Circled Items
2
Paraphrased
Correctly/Concept
Understood
3
Comments
4
Modified Brief Pain Inventory-
Short Form (mBPI-sf)
YES
1. Have you experienced any
pain in the past 24 hours?
YES Two subjects preferred the wording “viimeksi kuluneiden 24 tunnin
aikana” (during the last 24 hours) and said it to sound “better Finnish”.
Resolution: No change. Stylistic preference.
No YES
Yes YES Two subjects suggested changing the affirmative word “on” (yes) to the
affirmative word “kyllä” (yes).
Interviewer: “On” (yes) is more commonly used in spoken language, but it
understandable as it is used here.
Resolution: No change. Stylistic preference.
If you answer NO to question
one (1), please stop now.
YES All subjects suggested changing both this item and the one following to
past tense, since the question has already been answered.
Resolution: No change. Stylistic preference. Translation accurately
reflects the original English and all subjects understood the concept.
If you answer YES, complete the
questionnaire.
YES
2. On this scale, how much pain
are you having right now?
YES
No Pain YES
Worst pain possible YES
3. On this scale, please indicate
the worst pain you have had in
the past 24 hours.
YES
4. On this scale, please indicate
the average level of pain you
have had in the past 24 hours.
YES
Please mark X the number
below that describes how,
during the past 24 hours, pain
has interfered with your:
YES Four subjects suggested changing “haittaa täysin” (completely interferes)
to the present tense, or changing the responses to past tense, so the
tenses of the question and responses are consistent.
Interviewer agrees but translation reflects the source language so no
change is recommended.
Resolution: No change. Stylistic preference. Translation reflects the
original English and all subjects understood the concept.
A. General activity YES
Does not interfere YES
Completely interferes YES
B. Mood YES
C. Walking ability YES
D. Relations with other people YES
E. Sleep YES
F. Normal Work, including
housework
YES Two subjects suggested changing “taloustyöt” (housework) to “kotityöt”
(homework) because it is more common and does not mean work done
for school.
Interviewer: “Taloustyöt” is not wrong but “kotityöt” is more common.
Resolution: Change accepted. Translation team agrees that
“kotityöt” is a more common way of expressing the concept.
G. Enjoyment of life YES
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healthcare provider-patient communication and treat-
ment outcomes in clinical practice and be useful for
assessing goal achievement in clinical trials. Multiple
language iterations should help communication between
patients and physicians in different countries, which
could lead to more consistent assessment and treatment
of the LUTS that are most bothersome to individual
patients. Time spent to ensure that patients are able to
understand each question being asked, especially consid-
ering the variations among languages, is expected to
help guide physicians with treatment decisions. The
measurement properties of the translated versions will
be presented at upcoming international research
symposia.
Conclusions
Translations of the SAGA questionnaire from English to
12 European languages adequately captured the con-
cepts in the original English version of the question-
naire, thereby demonstrating the conceptual, semantic,
and cultural equivalence of each translation. Participants
with LUTS demonstrated an ability to understand the
concepts in the questionnaire, with an overall compre-
hension rate of 98.9%. Based on the results of cognitive
debriefing interviews of participants reporting LUTS,
minor changes were made to 7 of the 12 translations to
improve clarity and comprehension.
Appendix A. Appendix A. Translation and
Harmonization Procedures (V1.0)
1. Two translators who are native speakers of the target
language and are experienced in translating health ques-
tionnaires independently translate the document.
2. After both translations are complete, the two trans-
lators compare their translations and produce a third
translation jointly. This process of discussion and review
is known as “harmonizing” and the resulting third trans-
lation is referred to as the “harmonized translation.”
3. The harmonized translation is then given to a
native English-speaking translator for translation back
into English. This document is referred to as the “back-
translation.”
4. A project manager compares the original English to
the back-translation and either approves or questions
each item in the back-translation.
5. The project manager discusses concerns with the
three translators, who may change the translation,
change the back-translation, or leave the translation as
it is, providing a justification to the project manager. A
new harmonized translation and back-translation may
be created.
6. A survey research consultant (or document author,
if available) compares the original English to the
harmonized back-translation and either approves or
questions each item.
7. If portions of the back-translation are not approved,
then the translation is sent back to the three translators
who may change the translation, change the back-trans-
lation, or leave the translation as it is, providing a justifi-
cation to the survey research consultant (or author).
This process is repeated until all translation issues have
been resolved and the revised back-translation is
approved.
8. Local users selected by the client review the transla-
tion to identify any additional concerns. If the local user
requests changes, the steps are repeated until all con-
cerns have been addressed and all revisions are
approved by the survey research consultant (author).
Appendix B. Appendix B. Sample Data Collection
Form (DCF)
T h es a m p l eD C F si l l u s t r a t ethe two steps in the collec-
tion and analysis of cognitive debriefing data, as follows:
1. Interviewers complete and submit a DCF for each
subject as specified in the Cognitive Debriefing Manual.
2. Interviewers compile DCFs into a Summary DCF
and submit the Summary DCF.
The interviewer should label the Summary DCF with
the language code, e.g., SW-SW Summary DCF is the
label for the Swedish for Sweden Summary DCF.
At the top of the DCF, the interviewer enters the
interview begin and end times. The subject’sd e m o -
graphics and the time to complete the interview (elapsed
time) are entered into the boxes that correspond to the
subject’s ID#. On the Summary DCF, the interviewer
enters the demographic information for all participants.
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